These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2089982)
41. [Role of alveolar macrophages and neutrophils in the defense system against infection of Pseudomonas aeruginosa in the respiratory tract and the effect of derivative of muramyl dipeptide]. Maeda M; Ozaki T; Yasuoka S; Ogura T Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):135-42. PubMed ID: 2355674 [TBL] [Abstract][Full Text] [Related]
42. Defense mechanisms of the respiratory membrane. Green GM; Jakab GJ; Low RB; Davis GS Am Rev Respir Dis; 1977 Mar; 115(3):479-514. PubMed ID: 320925 [TBL] [Abstract][Full Text] [Related]
43. Effect of nutrition on nonspecific inflammatory and specific immune host defense systems. Miller CL J Med; 1980; 11(4):267-73. PubMed ID: 6943259 [TBL] [Abstract][Full Text] [Related]
44. Interference of Pseudomonas aeruginosa with immunospecific host defenses. Petit JC; Daguet GL Biomed Pharmacother; 1983; 37(9-10):422-8. PubMed ID: 6232960 [TBL] [Abstract][Full Text] [Related]
45. Oropharyngeal and gastrointestinal carriage in the critically ill. Van Saene HK; Stoutenbeek CP Agressologie; 1990; 31(8 Spec No):557-9. PubMed ID: 2089986 [TBL] [Abstract][Full Text] [Related]
46. Host defenses against respiratory tract infection: implications for anti-inflammatory drug development and treatment. Snell NJ Exp Lung Res; 2007 Dec; 33(10):529-36. PubMed ID: 18075827 [TBL] [Abstract][Full Text] [Related]
47. The interaction of infection and the adult respiratory distress syndrome. Niederman MS; Fein AM Crit Care Clin; 1986 Jul; 2(3):471-95. PubMed ID: 3331558 [TBL] [Abstract][Full Text] [Related]
48. Normal host defenses and impairments associated with the delayed resolution of pneumonia. Mason CM; Nelson S Semin Respir Infect; 1992 Dec; 7(4):243-55. PubMed ID: 1307128 [TBL] [Abstract][Full Text] [Related]
50. Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages. Oliver BG; Lim S; Wark P; Laza-Stanca V; King N; Black JL; Burgess JK; Roth M; Johnston SL Thorax; 2008 Jun; 63(6):519-25. PubMed ID: 18245149 [TBL] [Abstract][Full Text] [Related]
51. Similarities of host defense mechanisms against pulmonary infectious diseases in animals and man. Green GM J Toxicol Environ Health; 1984; 13(2-3):471-8. PubMed ID: 6376823 [TBL] [Abstract][Full Text] [Related]
52. Pulmonary host defenses. Implications for therapy. Mason CM; Nelson S Clin Chest Med; 1999 Sep; 20(3):475-88, vii. PubMed ID: 10516897 [TBL] [Abstract][Full Text] [Related]
53. Investigation of host defense mechanisms in the aged as determinants of nosocomial colonization and pneumonia. Phair JP; Kauffman CA; Bjornson A J Reticuloendothel Soc; 1978 May; 23(5):397-405. PubMed ID: 671426 [No Abstract] [Full Text] [Related]
54. Current concepts on pulmonary host defense mechanisms in children. Wilmott RW; Khurana-Hershey G; Stark JM Curr Opin Pediatr; 2000 Jun; 12(3):187-93. PubMed ID: 10836151 [TBL] [Abstract][Full Text] [Related]